Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $118.17 | 5 | 79.8% |
| Education | $29.99 | 1 | 20.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $73.89 | 3 | $0 (2019) |
| Astellas Pharma US Inc | $41.56 | 2 | $0 (2019) |
| ViiV Healthcare Company | $32.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $55.22 | 2 | Astellas Pharma US Inc ($29.99) |
| 2018 | $48.66 | 2 | Gilead Sciences, Inc. ($48.66) |
| 2017 | $44.28 | 2 | ViiV Healthcare Company ($32.71) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $29.99 | General |
| 05/28/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.23 | General |
| 06/14/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.44 | General |
| 02/22/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.22 | General |
| 10/05/2017 | ViiV Healthcare Company | TIVICAY (Drug) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: HIV | ||||||
| 01/12/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Infectious Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 105 | 152 | $47,879 | $12,817 |
| 2022 | 5 | 122 | 200 | $47,822 | $14,317 |
| 2021 | 5 | 145 | 263 | $60,214 | $18,286 |
| 2020 | 6 | 130 | 185 | $39,784 | $13,767 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 75 | $17,025 | $4,589 | 27.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $12,450 | $3,400 | 27.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 31 | $10,571 | $2,892 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $7,833 | $1,936 | 24.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 112 | $20,944 | $6,317 | 30.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 26 | $9,256 | $2,799 | 30.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $8,857 | $2,568 | 29.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 25 | $6,725 | $2,035 | 30.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 20 | $2,040 | $597.11 | 29.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 54 | 136 | $24,480 | $7,450 | 30.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 20 | 23 | $11,569 | $3,596 | 31.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 45 | $11,610 | $3,525 | 30.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 28 | $9,548 | $2,855 | 29.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 19 | 31 | $3,007 | $859.19 | 28.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 40 | 65 | $11,418 | $3,998 | 35.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 25 | 25 | $8,120 | $2,841 | 35.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 28 | $7,080 | $2,325 | 32.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 23 | $4,692 | $1,786 | 38.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $5,273 | $1,759 | 33.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 22 | 33 | $3,201 | $1,059 | 33.1% |
About Dr. Susan Fraser, MD
Dr. Susan Fraser, MD is a Infectious Disease healthcare provider based in Tacoma, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932187663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Fraser, MD has received a total of $148.16 in payments from pharmaceutical and medical device companies, with $55.22 received in 2019. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($118.17).
As a Medicare-enrolled provider, Fraser has provided services to 502 Medicare beneficiaries, totaling 800 services with total Medicare billing of $59,188. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Tacoma, WA
- Active Since 01/03/2006
- Last Updated 10/06/2023
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1932187663
Products in Payments
- TIVICAY (Drug) $32.71
- Cresemba (Drug) $11.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Tacoma
Lawrence Schwartz, Md, MD
Infectious Disease — Payments: $2,562
Dr. Roumen Iordanov, M.d, M.D
Infectious Disease — Payments: $1,039
Elizabeth Lien, M.d, M.D
Infectious Disease — Payments: $934.00
Dr. Michael Stein, M.d, M.D
Infectious Disease — Payments: $482.02
David Mceniry, M.d, M.D
Infectious Disease — Payments: $164.10
Ramona Popa, Md, MD
Infectious Disease — Payments: $153.91